• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.

作者信息

Molinari G, Schito G C

机构信息

Institute of Microbiology, University of Genoa Medical School, Italy.

出版信息

Drugs. 1995;49 Suppl 2:222-5. doi: 10.2165/00003495-199500492-00048.

DOI:10.2165/00003495-199500492-00048
PMID:8549310
Abstract
摘要

相似文献

1
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.BAY Y 3118与其他氟喹诺酮类药物的体外活性比较
Drugs. 1995;49 Suppl 2:222-5. doi: 10.2165/00003495-199500492-00048.
2
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.从慢性中耳炎和慢性鼻窦炎分离出的细菌菌株对环丙沙星的体外敏感性。
Drugs. 1995;49 Suppl 2:200-2. doi: 10.2165/00003495-199500492-00041.
3
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.三种氟喹诺酮类药物、头孢噻肟和克林霉素对葡萄球菌的体外活性
Zentralbl Bakteriol. 1995 Oct;282(4):389-93. doi: 10.1016/s0934-8840(11)80709-7.
4
Comparative in vitro activity of BAY Y 3118 against selected species.
Drugs. 1995;49 Suppl 2:264-5. doi: 10.2165/00003495-199500492-00064.
5
In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.新型喹诺酮BAY y 3118对厌氧菌的体外活性
Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):640-2. doi: 10.1007/BF01973648.
6
Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria.使用环丙沙星耐药菌预测菌组对克林沙星与环丙沙星、氟罗沙星、氧氟沙星和司帕沙星进行交叉耐药性分析。
J Antimicrob Chemother. 1995 Aug;36(2):431-4. doi: 10.1093/jac/36.2.431.
7
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.三种研究性氟喹诺酮类药物（BAY y 3118、DU-6859a和克林沙星）对环丙沙星和氧氟沙星敏感性降低的淋病奈瑟菌分离株的活性。
Antimicrob Agents Chemother. 1995 Jul;39(7):1606-8. doi: 10.1128/AAC.39.7.1606.
8
Comparative in vitro activities of new quinolones against coryneform bacteria.新型喹诺酮类药物对棒状杆菌的体外活性比较
Antimicrob Agents Chemother. 1994 Jun;38(6):1439-41. doi: 10.1128/AAC.38.6.1439.
9
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.八种喹诺酮类药物对脆弱拟杆菌群成员的比较活性
Antimicrob Agents Chemother. 1994 Jun;38(6):1442-5. doi: 10.1128/AAC.38.6.1442.
10
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.司帕沙星与环丙沙星及氧氟沙星相比对呼吸道病原体的体外活性。
Chemotherapy. 1993;39(1):32-5. doi: 10.1159/000238970.

引用本文的文献

1
Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones.R8取代基对贝西沙星及对照眼科氟喹诺酮类药物体外抗菌效力的贡献。
Clin Ophthalmol. 2013;7:821-30. doi: 10.2147/OPTH.S44085. Epub 2013 May 3.

本文引用的文献

1
The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.新型氯氟喹诺酮类药物Bay y 3118的体外活性
J Antimicrob Chemother. 1993 Jan;31(1):73-80. doi: 10.1093/jac/31.1.73.
2
In vitro activity of Bay Y3118 against anaerobic bacteria.Bay Y3118对厌氧菌的体外活性。
Antimicrob Agents Chemother. 1993 Nov;37(11):2509-13. doi: 10.1128/AAC.37.11.2509.
3
In vitro activity of Bay y 3118, a new quinolone.新型喹诺酮类药物Bay y 3118的体外活性
Antimicrob Agents Chemother. 1993 Nov;37(11):2348-57. doi: 10.1128/AAC.37.11.2348.
4
In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.新型喹诺酮BAY y 3118对厌氧菌的体外活性
Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):640-2. doi: 10.1007/BF01973648.
5
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.428株革兰氏阳性和阴性厌氧菌对Bay y3118的敏感性及其对环丙沙星、克林霉素、甲硝唑、哌拉西林、哌拉西林-他唑巴坦和头孢西丁的敏感性比较。
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
6
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.新型喹诺酮类药物Bay y 3118与环丙沙星、司帕沙星、妥舒沙星、CI-960和CI-990的体外活性比较
J Antimicrob Chemother. 1993 Apr;31(4):505-22. doi: 10.1093/jac/31.4.505.
7
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.在美国引起感染的肠球菌常见及罕见菌种的抗菌药敏模式。肠球菌研究小组。
J Clin Microbiol. 1992 Sep;30(9):2373-8. doi: 10.1128/jcm.30.9.2373-2378.1992.
8
In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.新型全谱氟喹诺酮BAY Y3118的体外评价
Chemotherapy. 1992;38(6):376-87. doi: 10.1159/000239031.